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Am J Med Genet Part B 171B:733–747.harmful to individuals and society. With an estimated herita-
bility of about 40%, genetics is important in its development.We
performed an exploratory genome-wide association (GWA)
analysis of childhood aggressiveness in attention deficit hyper-
activity disorder (ADHD) to gain insight into the underlying
biological processes associated with this trait. Our primary
sample consisted of 1,060 adult ADHD patients (aADHD). To
further explore the genetic architecture of childhood aggres-
siveness, we performed enrichment analyses of suggestive
genome-wide associations observed in aADHD among GWA
signals of dimensions of oppositionality (defiant/vindictive
and irritable dimensions) in childhood ADHD (cADHD).
No single polymorphism reached genome-wide significance
(P< 5.00E-08). The strongest signal in aADHD was observed
at rs10826548,within a longnoncodingRNAgene (beta¼1.66,
standard error (SE)¼ 0.34, P¼ 1.07E-06), closely followed by
rs35974940 in the neurotrimin gene (beta¼ 3.23, SE¼ 0.67,
P¼ 1.26E-06). The top GWA SNPs observed in aADHD showed
significant enrichment of signals from both the defiant/vindic-
tive dimension (Fisher’s P-value¼ 2.28E-06) and the irritable
dimension in cADHD (Fisher’s P-value¼ 0.0061). In sum, our
results identify a number of biologically interesting markers
possibly underlying childhood aggressiveness and provide tar-
gets for further genetic exploration of aggressiveness across
psychiatric disorders.  2016 The Authors. American Journal of Medical
Genetics Part B: Neuropsychiatric Genetics Published by Wiley Periodicals, Inc.
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INTRODUCTION
Aggressiveness can be defined as any behavior directed toward an
individual with the immediate intent to cause harm [Anderson and
Bushman, 2002]. Violence, which is strongly related to aggres-
siveness, is the sixth leading cause of burden of disease for people
aged 15–44 years worldwide [WHO, 2008]. To date, most inter-
ventions designed to reduce violence risk typically have small effects,
reflecting our limited understanding of its causes and stressing the
need for further studies [Moffitt, 2005; McGuire, 2008].
As a complex phenomenon, aggressiveness spans across numer-
ous facets of human behavior, ranging from emotional lability and
temperamental traits (e.g., hot-tempered, short fuse, irritable) to
physical violence [Lesch et al., 2012]. These traits are frequently
found among youth with attention deficit hyperactivity disorder
(ADHD), a common child and adolescent psychiatric disorder
with a prevalence of about 5% and a rate of persistence into
adulthood of about 50% [Faraone et al., 2015]. ADHD is defined
by symptoms of inattention and hyperactivity/impulsivity, and
youth with ADHD often have co-existing disorders, some of which
are closely related to aggressiveness and violence, such as conduct
disorder (CD) and/or oppositional defiant disorder (ODD) and
disorders characterized by symptoms defined within the broader
term of antisocial behavior [Dalsgaard et al., 2002]. These disorders
put youth with ADHD at high risk of problems associated with
aggressiveness in adulthood [Klassen et al., 2010], especially when
the aggressive behavior has an early onset [Hofvander et al., 2009].This can be illustrated by the fact that around 30% of youth and
25% of adult prison inmates are found to qualify for an ADHD
diagnosis [Young et al., 2014]. Studies of childhood aggressiveness
in adults can, therefore, be of great importance to improve our
understanding of adult ADHD.
The etiology of ADHD as well as traits of aggressiveness is
complex, with genetics playing an important role. The heritability
of ADHD has been estimated to be up to 88% across the lifespan
[Larsson et al., 2013], whereas the estimates of genetic influence on
aggression vary across studies, collectively reaching about 40–50%
[Brendgen et al., 2006; Tuvblad and Baker, 2011]. Such diversity in
the estimation of aggression heritability may result from inconsis-
tency in measures across studies. Several different aggression
measures have been utilized to assess the genetic and environmen-
tal influences on its development [Veroude et al., 2015], reflecting
that there is no consensus regarding its definition [Ramirez and
Andreu, 2006]. Furthermore, the estimates of aggressiveness are
influenced by the age of the study participants. The literature
reports stability of aggressiveness between childhood and adult-
hood, with adolescence as a transient period with little stability in
this trait [Moffitt, 2005]. Genes seem to explain little variation in
adolescent aggression, but are likely to account for individual
differences in childhood and adult aggression [Lyons et al.,
1995]. Also, given higher levels of aggression in males and higher
genetic load inmales with antisocial behavior compared to females,
it is an open question whether genetic propensity is of greater
importance in one sex over the other [Miles and Carey, 1997;
Tuvblad and Baker, 2011]. Interestingly, similar considerations of
age and sex effects are also present in studies of ADHD as well as
when ADHD is co-morbid with aggressive behavior [Faraone
et al., 1991, 2015].
Given that ADHD and aggression often co-occur and that both
traits are heritable, twin studies have noted the possibility of shared
genetic etiology between ADHD and aggression. A common
genetic factor has been reported among ADHD and symptoms
of aggression in 9–10-year-old children [Tuvblad et al., 2009].
Likewise, it has been suggested that impulsivity and aggression are
genetically mediated to a similar extent [Seroczynski et al., 1999].
Influenced by major theories on neuronal circuits, genetic
association studies of ADHD and/or aggression have been domi-
nated by candidate gene studies, focusing on the regulation of
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2015]. In line with twin studies, these candidate gene analyses have
provided further support toward a shared genetic component
between ADHD and aggression. Many genes associated with
ADHD point toward the same biological mechanisms as those
associated with aggressive behavior, including genes that are
involved in the synthesis, binding, transport and degradation of
neurotransmitters, especially dopamine and serotonin [Faraone
et al., 2015; Veroude et al., 2015]. It has been reported, for example,
that the genesMAOA, DRD2, DRD4, COMT, SLC6A4, TPH1, and
TPH2 may contribute to the development of ADHD as well as
aggressive behaviors [Gizer et al., 2009; Vassos et al., 2014].
However, these candidate gene studies suffer from the lack of
replication in independent samples (where available) and small
effect sizes suggest that some of these genes play amore limited role
in the susceptibility to ADHD and/or aggressive behavior, or that
their involvement may be limited to rare familial cases [McKinney
et al., 2008; Halmoy et al., 2010; Tiihonen et al., 2014]. Thus, the
overall genetic architecture of ADHD and/or aggression remains
largely unknown and warrants studies using a hypothesis-free
approach [Vassos et al., 2014].
Genome-wide association (GWA) studies allow interrogation
of the entire genome to generate new hypotheses. To date, few
GWA studies have been performed for ADHD and/or aggres-
siveness, with no finding passing the stringent Bonferroni-
corrected genome-wide significance level (P< 5.00E-08) for
either phenotype [Dick et al., 2011; Tielbeek et al., 2012; Mick
et al., 2014; Salvatore et al., 2015]. Nonetheless, as these studies
were generally underpowered, some understanding of biological
processes behind ADHD and/or aggressiveness may emerge from
the convergence of identified nominally significant loci. Previous
GWA studies on aggressive behaviors in ADHD have noted a
number of suggestive association signals, generating biological
hypotheses regarding the etiology of ADHD and/or aggression
[Anney et al., 2008; Aebi et al., 2015]. In addition, a recent GWA
study revealed a positive linear correlation between ADHD
polygenic scores and comorbid aggression scores, indicating
that the presence of aggressive symptoms in ADHD is likely to
index a greater genetic load [Hamshere et al., 2013]. Similarly
hypothesis-free, genome-wide linkage analyses have also reported
evidence of significant co-segregation between ADHD and dis-
ruptive behavior [Jain et al., 2007].
The lack of robust genetic association signals may be explained
by the modest sample sizes and the complex nature of both
ADHD and aggressiveness, where genetic factors are intertwined
with environmental influences [Brendgen et al., 2006]. In addi-
tion, heterogeneity in genetic susceptibility, phenotypic manifes-
tation, and operationalization of aggressiveness may depress
association signals [Cross-Disorder Group of the Psychiatric
Genomics et al., 2013]. The phenotypic heterogeneity in
ADHD may potentially be exacerbated by its high rates of
comorbidity with not only aggressive behaviors, but also
mood and anxiety disorders [Biederman et al., 1992]. Another
possible reason behind the lack of replicable genetic findings is
the limited annotation of the human genome. The annotation
has mostly been focused on protein-coding genes that represent
only 1% of our genome, making it difficult to evaluate possiblebiological pathways involved in ADHD and/or aggressiveness, as
the majority of GWA findings tend to reside outside the tradi-
tional protein-coding regions [Dick et al., 2011; Schizophrenia
Working Group of the Psychiatric Genomics, 2014].
In the present study, we aimed to perform exploratory genome-
wide association tests to shed light on the genetic susceptibility loci
and biological processes possibly involved in the etiology of
childhood aggressiveness in ADHD.We utilized the GWAmethod
to analyze childhood aggressiveness in adults with ADHD gathered
in studies across Europe. To minimize phenotypic heterogeneity
between samples, we derived our measure of childhood aggres-
siveness in adult ADHD (aADHD) from the Wender Utah Rating
Scale (WURS). This questionnaire was used as part of the assess-
ment procedure at all sites. As the WURS reflects childhood
recollections, we also explored a possible genetic overlap of associ-
ation signals observed in aADHD with those of irritable and
defiant/vindictive dimensions of ODD in youth with ADHD
(cADHD) [Aebi et al., 2015]. Finally, we performed an examina-
tion of non-protein coding genes in order to obtain a better
understanding of the biological processes underlying childhood
aggressiveness in aADHD.
MATERIALS AND METHODS
Subjects
aADHD samples. Recruitment of adult ADHD patients
was conducted at three sites within an international multi-
center persistent ADHD collaboration (IMpACT, http://www.
impactadhdgenomics.com): Germany, Norway, and Spain. All
individuals were of Caucasian ancestry. Only participants who
gave written informed consent were enrolled in the studies, which
complied with the Declaration of Helsinki.
German sample. Patients with a diagnosis of aADHD were
recruited by experienced psychiatrists at the University of
W€urzburg (W€urzburg, Germany). Unrelated in- and outpatients
of self-reported central-European descent completed a semi-
structured clinical interview according to DSM-IV. Inclusion
criteria were onset before the age of 7 years, lifelong persistence,
current diagnosis and age of recruitment between 18 and 65 years.
Exclusion criteria were the appearance of symptoms restricted to
the duration of any otherAxis I disorder; current diagnosis of active
alcohol or other drug abuse or dependence; lifetime diagnosis of
bipolar I disorder, schizophrenia, or any other psychotic disorder;
and an IQ score below 80. For a more detailed sample description,
please confer previous publications [Reif et al., 2009; Franke et al.,
2010]. The study was approved by the Ethic Committee of the
University of W€urzburg (W€urzburg, Germany).
Norwegian sample. Participants were recruited at the Univer-
sity of Bergen (UiB, Bergen, Norway) as described elsewhere
[Halmoy et al., 2009]. In short, adult patients with ADHD were
recruited through a Norwegian national medical registry as well as
by psychologists and psychiatrists working at outpatient clinics. All
patients had been previously diagnosed with ADHD using either
DSM-IV or ICD-10. The ICD-10 criteria were adapted to theDSM-
IV criteria by allowing the inattentive subtype as sufficient for the
ADHD diagnosis. Individuals with other neuropsychiatric disor-
ders were not excluded as long as the ADHD criteria were fulfilled.
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participants provided either blood or saliva samples for DNA
extraction. The study was approved by the regional committee
for medical and health research ethics, western Norway.
Spanish sample. Participants were recruited at the Depart-
ment of Psychiatry from the Hospital Universitari Vall d’Hebron
(HUVH, Barcelona, Spain) as described elsewhere [Sanchez-Mora
et al., 2015]. Patients were adults of Caucasian origin and met
Diagnostic and Statistical Manual for Mental Disorders-IV (DSM-
IV) criteria for ADHD. The diagnosis of ADHDwas evaluated with
the Structured Clinical Interview for DSM-IV Axis I and II Dis-
orders (SCID-I and SCID-II) and the Conner’s Adult ADHD
Diagnostic Interview for DSM-IV (CAADID Parts I and II).
Consensus eligibility criteria for the current study were a diagnosis
of ADHD according to the diagnostic criteria of DSM-IV, onset
before the age of 7 years via retrospective diagnosis (which was
confirmed by a family member, wherever possible), lifelong per-
sistence and current diagnosis. DNA was extracted from either
peripheral blood or saliva samples. The study was approved by the
ethics committee of the institution.
cADHD sample. Youth with ADHD were participants in the
International Multicentre ADHD Genetics (IMAGE) study,
recruited in 12 children and adolescent psychiatry clinics repre-
senting eight countries across Europe. Approval was obtained by
the Institutional Review Board of SUNY Upstate Medical Univer-
sity and from ethical review boards within each country. A detailed
description of the study design and assessment procedures has been
provided in previous publications [Muller et al., 2011a,b]. In short,
entry criteria for probands were a clinical diagnosis of ADHD
according to DSM-IV-based structured interviews and access to
one or both biological parents and one or more full siblings for
DNAcollection and clinical assessment. Exclusion criteria included
autism, epilepsy, IQ< 70, brain disorders, and any genetic or
medical disorder associated with externalizing behaviors that
might mimic ADHD.Measures of Aggressiveness
aADHD samples. The adult measure of childhood aggres-
siveness in the aADHD samples was derived from the Wender
Utah Rating Scale (WURS) [Ward et al., 1993]. The WURS is a
questionnaire used for retrospective assessment of childhood
symptoms of ADHD in adults. An exploratory factor analysis
(EFA) was run to determine the latent structure of the WURS.
The EFA consisted of a principal component analysis with Varimax
rotation and yielded three factors with Eigen values above one.
From themain factor explaining the greatest amount of variance in
responses to the WURS (30.7%), the top six items with the highest
loadings (0.74–0.82) all represented prototypical elements of
aggressiveness: “temper outburst/tantrums,” “angry,” “hot- or
short-tempered/low boiling point,” “disobedient with parents/
rebellious/sassy,” “losing control of myself,” and “irritable,” For
each item, the participant was asked to evaluate if she/he as a child
was (or had) a specific symptom and to rate it according to the
following four response categories: “not at all/very slightly” (0),
“mildly” (1), “moderately” (2), quite a bit” (3), or “verymuch” (4).
The arithmetic sum of the responses of the aforementioned itemswas adopted as a continuous measure of aggressiveness, ranging
from 0 to 24. Supplementary Figure S1 shows the distribution of
this measure across genders in the three aADHD datasets.
cADHD sample. The dimensions of oppositionality were
assessed using the long form of the revised Conners Parent Rating
Scale (CPRS-R:L) [Conners et al., 1998]. The defiant/vindictive
and irritable dimensions of ODD were defined on theoretical
grounds as described elsewhere [Aebi et al., 2015], and reflect
two previously described dimensions of ODD [Stringaris et al.,
2012; Aebi et al., 2013].Genotype Data
Genotyping of each sample was performed by each of the four
participating groups, individually. To maximize available genetic
information among examined datasets, genetic imputation was
carried out independently at each site.aADHD Samples
German sample. Genotyping of participants was performed
on Illumina’s PsychChip array (Illumina, San Diego, CA) at the
Broad Institute (Cambridge,MA) using the PsychChip 15048346 B
manifest. Genotypes were assigned in Illumina’s GenomeStudio
v2010.3, using the calling algorithm/genotyping module version
1.8.4. Quality control procedures were performed as described
previously, with lightly modified exclusion criteria (SNPs exhibit-
ing missingness above 98%; minor allele frequency below 5%;
failingHardy–Weinberg equilibrium test [P< 104]) [Zayats et al.,
2015]. Genotype imputation was performed with SHAPEIT/
IMPUTE2 pipeline as described elsewhere, using 1000 Genomes
Phase 3 data as a reference [Marchini et al., 2007;Howie et al., 2009;
Cross-Disorder Group of the Psychiatric Genomics, 2013].
Norwegian sample. Participants were genotyped on Human
OmniExpress-12v1-1_B (Illumina, San Diego, CA) platform at the
deCODE Genetics facility (Reykjavik, Iceland). Genotyping and
quality control procedures are described elsewhere [Zayats et al.,
2015]. Imputation was performed utilizing IMPUTE software as
previously detailed [Marchini et al., 2007;Howie et al., 2009; Cross-
Disorder Group of the Psychiatric Genomics, 2013].
Spanish sample. Genome-wide genotyping was performed
with the Illumina HumanOmni1-Quad BeadChip platform. Qual-
ity control was implemented at the individual and SNP level using
PLINK and included filtering subjects with low call rate (<98%) or
gender discrepancy followed by filtering SNPs with minor allele
frequency (MAF)< 0.01, Hardy–Weinberg equilibrium test
P-values< 1e-06 or call rate< 0.99 in either cases or controls.
Imputation was performed using BEAGLE software [Browning
and Browning, 2007].
cADHD sample. Sample collection and DNA isolation has
been described previously [Brookes et al., 2006]. Genome-wide
genotyping and quality control was performed as part of the GAIN
study using the Perlegen 600K genotyping platform, as previously
described [Neale et al., 2008]. The imputationwas performed using
MACH and the Hapmap 2 (Release 22 Build 36) reference data set
[Li et al., 2010]. Quality control was performed on the imputed
data, and SNPs with imputation quality scores lower than 0.30, a
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Hardy–Weinberg equilibrium test at a threshold of P 105
were excluded. SNPs and subjects with missingness rates higher
than 0.05 were removed from the data.Statistical Analyses
The age and gender distributions between the aADHDand cADHD
samples were assessed using x2 for gender and ANOVA for age.
Genome-wide association (GWA) of aggressiveness. In the
aADHD sample, single nucleotide polymorphisms (SNPs) were
tested for association with the WURS-derived measure of aggres-
siveness in the form of linear regression carried out in PLINK using
post-imputation dosage data [Purcell et al., 2007]. Regression
models were adjusted for age and sex. Genotype data of each site
were first processed individually. The results were then combined
with the use of fixed-effects inverse variance meta-analysis in
METAL [Willer et al., 2010]. Only SNPswithminor allele frequency
(MAF)equal toor above1%and imputation INFOmeasure equal to
or above 0.6 were included in the analyses. Genomic control, QQ
plotting, and regional plotting of top loci were applied to check the
integrity of test statistics [Devlin and Roeder, 1999; Cuellar-Partida
et al., 2015]. The genomic inflation factor was calculated using
METAL [Willer et al., 2010]. A genome-wide significance threshold
of 5.00E-08 was adopted to correct for multiple testing.
GWA analyses of irritable and defiant/vindictive dimensions of
ODD in cADHD sample was performed in PLINK software in the
form of linear regression adjusted for sex and age [Purcell
et al., 2007]. Details of the analyses are described elsewhere
[Aebi et al., 2015].
Gene-based and Gene-set association of aggressiveness in the
aADHD meta-analyzed sample. Gene-based and gene-set path-
way analysis were performed in the aADHD sample carried out in
MAGMA software [de Leeuw et al., 2015]. First, a degree of
association was calculated for each gene based on METAL-derived
individual SNPs’ P-values, using 1000 Genomes CEU dataset as a
reference panel to correct for linkage disequilibrium (LD)
[Genomes Project et al., 2012]. To evaluate each gene’s contribu-
tion to examined gene-sets (gene-set pathway analysis), the P-value
of each gene was converted to a Z-value and used as an outcome
variable in a regression model with gene-set membership as a
predictor. Gene size and gene-sets’ gene density were added as
covariates to adjust for possible confounding effects and prevent
spurious association.
For gene-based tests, we assessed the association with both
protein and non-protein-coding genes. The protein-coding gene
list was curated from the catalog of known genes downloaded from
the Genome Browser of the University of California Santa Cruz
(UCSC, CA). The non-protein-coding genes were examined in the
form of long non-coding RNA (lncRNA) genes detailed in the
aforementioned catalog. For gene-set pathway analysis, we exam-
ined structural categories of gene ontology (GO, http://
geneontology.org), with respect to cellular function, biological
process and cellular compartments. To achieve meaningful statis-
tics and interpretation of the results, we restricted our pathway
analysis to those GO terms that contained SNPs in at least 10 genes
per term in our aADHD data.Genome-wide enrichment analyses between GWA results in
aADHD and cADHD samples. Prior to performing enrichment
analyses, the genetic data in both aADHD and cADHD samples
were pruned to remove correlated loci in linkage disequilibrium
(LD) with each other. A pairwise correlation coefficient (r2)
threshold of 0.2 and the 1000 Genomes CEU reference dataset
were used to identify independent SNPs, as previously described
[Lindgren et al., 2009; Genomes Project et al., 2012].
Enrichment was examined by means of Fisher’s test performed
in the R software, assessing the difference in proportion of
SNPs revealing association P-values below 0.05 in the cADHD
sample according to suggestive association in the aADHD sample
(P-value belowor equal to 1.00E-03 versusP-value above 1.00E-03)
[Rahmioglu et al., 2015]. Consistency in directionality of SNP
effects with indication of enrichment between aADHD and
cADHD samples was tested as linear regression on the effect
(beta) of each SNP for aADHD as an outcome and for cADHD
(either irritable or defiant/vindictive dimensions of ODD, respec-
tively) as predictor variables [Do et al., 2013].
Examination of previously reported aggressiveness-related
candidate GWA loci. We assembled a list of previously reported
candidate GWA loci associated with aggressive behavior by
systematic literature search the catalog of published genome-
wide association studies provided by National Human Genome
Research Institute (NHGRI) (https://www.genome.gov/26525384),
using key words of “aggression,” “anger,” “violence,” as well as
“conduct disorder” and “antisocial personality disorder.” Each
identified candidate GWA locus was then looked up in meta-
analyzed aADHD sample.RESULTS
Subjects, Measure of Aggressiveness, and
GWA Analyses
In total, 1,060adultpatientsaswell as750childrenandadolescentswith
ADHD were available for the analyses. The age ranges in the aADHD
samples were 17–75 in the German sample, 18–57 in the Norwegian
sample, and 17–60 in the Spanish sample. In the cADHD sample, the
age range was 5–17. Details of the final samples are summarized in
Table I. Supplementary Figure S1 presents the distribution of the
selected measure of aggressiveness in each aADHD dataset.
After quality control of imputed SNPs in the adult samples,
9.301.568 SNPs were available for the analyses in the German
sample, 8.910.491 SNPs in the Norwegian sample, and 6.683.176
SNPs in the Spanish sample. Among these three datasets, 7.576.458
autosomal SNPs were present in at least two and, thus, were meta-
analyzed to assess genetic architecture of childhood aggressiveness
in aADHD. In cADHD sample, 1.871.025 autosomal SNPs were
available for the analyses.
IndividualGWAanalyses revealednogenome-wide significanthits
(P 5.00E-08) in either aADHD sample (not shown) nor in the
cADHD sample (Supplementary Table SI and Fig. S2). None of the
variants in the meta-analysis reached the Bonferroni-corrected
genome-wide significance level (P 5.00E-08) either. The strongest
signal was observed at rs10826548 on chromosome 10 located within
the transcript of a long noncoding RNA (lncRNA) (beta¼1.66,
TABLE I. Details of the ADHD Patient Samples
aADHD samples
IMpACT site Number of participants Females (%) Age (mean SD) Aggressiveness score (mean SD)
Germany 368 53.0 35.18 10.53 11.33 5.17
Norway 293 52.6 32.61 11.00 12.10 6.39
Spain 399 32.3 31.31 12.39 10.19 6.15
Total 1,060 45.1 33.01 11.51 11.11 5.94
cADHD sample
ODD scores (mean SD)
Number of participants Femalesa (%) Ageb (mean SD) Irritable Defiant/vindictive
IMAGE 750 12.3 10.67 2.77 7.75 3.06 8.95 4.18
SD, standard deviation.
Aggressiveness score was derived from WURS in the aADHD sample. In the cADHD sample, dimensions of oppositionality (irritable and defiant/vindictive dimensions) were examined [Aebi et al., 2015].
aDifference in the proportion of females between the aADHD and cADHD samples: P< 2.2E-16 (x2 test).
bDifference in age between the aADHD and cADHD samples: P< 2.2E-16 (ANOVA).
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followedby rs35974940 in the neurotrimin (NTM) gene (beta¼ 3.23,
SE¼ 0.67, P-value¼ 1.26E-06) (Fig. 2). Top associated markers
(P 1.00E-05) are summarized in Supplementary Table SII. The
genomic inflation factor was close to one for all individual andmeta-
GWA analyses in aADHD.QQplots of GWA analyses in aADHD are
presented in Supplementary Figure S3.
Gene-Based and Gene-Set Association
of Aggressiveness in the aADHD
Meta-Analyzed Sample
Among annotated protein-coding genes, 17.595 hadmore than one
SNP present in the aADHDdata. The strongest signal was noted for
the WD repeat domain 62 (WDR62) gene (P-value¼ 4.84E-05).
Supplementary Table SIII summarizes the top protein-coding genes
(P 1.00E-03) observed in aADHD sample. None of the protein-
coding gene-based tests survived the correction formultiple testing.
Among lncRNAgenes, 22.696 hadmore than one SNPpresent in
our aADHD data. The strongest association was observed for
ENST00000427806 (P-value¼ 3.04E-05). The top lncRNA genes
(P 1.00E-03) detected in this study are reported in Supplemen-
tary Table SIV. None of the non-protein-coding gene-based tests
survived the correction for multiple testing.
Among GO pathways, 1.945 terms contained SNPs in at least 10
genes per term in the aADHDdata. Themost prominent association
wasobserved for negative regulationof I-kappaBkinase/NF-kappaB
signaling pathway (GO:0043124 term, P-value¼ 7.26E-04). Sup-
plementary Table SV reports topGO terms (P 0.01) recognized in
this study. None of the GO pathways survived the correction for
multiple testing.
Genome-Wide Enrichment Analyses Between
GWA Results in aADHD and cADHD Samples
To assess potential genome-wide overlap of association signals
between measures of childhood aggressiveness in aADHD andcADHD, we investigated the independent (r2< 0.2) GWA sig-
nals of suggestive significance (P 1.00E-03) in aADHD for
enrichment in GWA signals of either defiant/vindictive or
irritable dimensions in cADHD. Given our modest sample
size, only those SNPs were considered in cADHD results that
revealed a P-value below or equal to 0.05 to avoid the examina-
tion of effects with a wide confidence interval. The top GWA
SNPs of WURS-derived childhood aggressiveness in aADHD
showed significant enrichment of signals from both the
defiant/vindictive dimension (Fisher’s P-value¼ 2.28E-06) and
the irritable dimension in cADHD GWA analysis (Fisher’s
P-value¼ 0.0061; Fig. 3A).
Next, we examined the directionality of effects of variants with
association signals in both aADHD and cADHD samples (P 1.00
E-03 in aADHD and P< 0.05 in cADHD). Significant correlation
between betas was observed in assessment of both oppositional
dimensions in cADHD and childhood aggressiveness in aADHD
(P¼ 0.0053 and 0.0045 for defiant/vindictive and irritable dimen-
sions respectively), but the direction of the relationship was nega-
tive (Fig. 3B andC). Supplementary Table SVII summarizes the top
hits (P 1-00E-05) observed in GWA meta-analysis of childhood
aggressiveness in aADHD and their corresponding statistics
observed in cADHD.Examination of Previously Reported
Aggressiveness-Related Candidate Genes
and GWA Loci
Among previously reported aggressiveness-related GWA loci,
several SNPs noted to be associated with anger, conduct disorder
and adult anti-social personality disorder revealed P-values
below 0.05 in our study (Supplementary Table SVIII). The
strongest signal in the GWA analysis of childhood aggressiveness
in aADHD among the aforementioned loci was observed for
rs4889240 in the PKD1L2 (polycystic kidney disease 1-like 2)
gene (beta¼0.73, SE¼ 0.25, P-value¼ 0.0039), previously
FIG. 1. Plot of the locus surrounding rs10826548. SNPs are plotted by position on chromosome 10 against GWA P-values for aggressive
behavior measure in aADHD. Estimated recombination rates from HapMap are plotted in bright red to reflect local LD structure. The SNPs
surrounding rs10826548 are color-coded to reflect their LD with it (according to pair-wise r2 values from the HapMap CEU database). SNPs
with LD r2 0.2 are plotted at the bottom of the graph with LD color-coding specified in the top right corner. “Genes” refers to protein-coding
genes in the presented region. “lincRNAsAllCellTypeTopView” reflects the data from lncRNA USCS track in brain tissue. “tfbsConsSites” reflects
the TFBS UCSC track.
BREVIK ET AL. 739reported to be associated with CD symptom count in ADHD
patients. The same SNP also revealed nominally significant
association in the same direction with the defiant/vindictive
dimension (beta¼0.54, SE¼ 0.21, P-value¼ 0.0094), but not
with the irritable dimension in cADHD. In this result, one should
keep in mind that the cADHD described here is a subsample of
the sample in which the original finding for rs4889240 was
described [Aebi et al., 2015]. Full results of our literature search
are presented in Supplementary Table SVIII.DISCUSSION
In this study, we performed a genome-wide exploration of child-
hood aggressiveness as reported retrospectively by adult patients
with ADHD (aADHD), examining both conventional protein-
coding and lncRNA genes. We also explored the overlap with
parent-reported oppositional behavior in youth with ADHD
(cADHD) and evaluated previously reported aggression-related
GWA loci. Given our modest sample size (1060 aADHD patients)
FIG. 2. Plot of the locus surrounding rs35974940. SNPs are plotted by position on chromosome 11 against GWA P-values for aggressive
behavior measure in aADHD. Estimated recombination rates from HapMap are plotted in bright red to reflect local LD structure. The SNPs
surrounding rs35974940 are color-coded to reflect their LD with it (according to pair-wise r2 values from the HapMap CEU database). SNPs
with LD r2 0.2 are plotted at the bottom of the graph with LD color-coding specified in the top right corner. “Genes” refers to protein-coding
genes in the presented region. “lincRNAsAllCellTypeTopView” reflects the data from lncRNA USCS track in brain tissue. “tfbsConsSites” reflects
the TFBS UCSC track.
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complex traits, it is not surprising that we did not observe any
genome-wide significant SNPs (P< 5.00E-08). Nonetheless, we
were able to identify several nominally significant variants
(P 1.00E-05) in biologically interesting genes for follow-up
studies of aggressiveness in ADHD, a feature of the disorder
that has received little attention so far.
The strongest signal in the performed single-point GWA tests
of childhood aggressiveness in aADHD was noted for rs10826548(beta¼1.16, SE¼ 0.34, P¼ 1.07E-06, Supplementary
Table SI). This variant resides in the transcript of a lncRNA
with uncertain coding potential (TCONS_00018147) (Fig. 1).
Non-protein coding RNAs play a critical role in the regulation of
gene expression and have been previously associated with neu-
ropsychiatric disorders, including ADHD [Perkins et al., 2005;
Gonzalez-Giraldo et al., 2015; Zayats et al., 2015]. In addition, it
has recently been observed that SNPs previously associated
with neurological and psychiatric conditions may be highly
FIG. 3. Enrichment and direction of effect among GWA signals of oppositional dimensions in cADHD and WURS-derived childhood
aggressiveness in aADHD. Part A reflects the proportion of SNPs nominally associated (P< 0.05) with each examined oppositional dimension
in cADHD (defiant/vindictive and irritable) among suggestive signals (P 1.00E-03) of association with childhood aggressiveness in aADHD.
Reported P-values are those of Fisher’s exact test. Parts B and C reflect directions of effect of 24 independent nominally significant loci in
GWA analyses of defiant/vindictive dimension in cADHD and childhood aggressiveness in aADHD (part B) as well as 17 independent nominally
significant loci in GWA analyses of irritable dimension in cADHD and childhood aggressiveness in aADHD (part C). Linear regression r2
measures and P-values are shown.
BREVIK ET AL. 741concentrated in the regions of long non-protein coding RNA
genes [Ning et al., 2014].
The second most significant locus identified in this study is
located within the neurotrimin (NTM) gene (intronic rs35974940,
P¼ 1.26E-06, Supplementary Table SI and Fig. S2). NTM is a
protein-coding gene, encoding a member of glycosylphosphatidy-
linositol (GPI)-anchored cell adhesion molecules, containing
immunoglobulin (Ig) domain. These proteins are predominantly
expressed in the central nervous system (CNS) [Struyk et al., 1995].
Among the association signals observed in NTM gene, several
have the potential to alter its expression. As determined in
the TRANSFAC database implemented in the SNPinfo server
of the National Institute of Environmental Health Sciences
(http://snpinfo.niehs.nih.gov), rs34588147 and rs35665773 (GWAP-values of 3.59E-06 and 3.25E-06, respectively, Supplementary
Table SI) are transcription factor binding sites (TFBS) (Fig. 2).
Moreover, two other SNPs in high linkage disequilibrium with the
aforementioned ones (rs12804059 and rs7119590, r2¼ 1 in CEU
population) also represent TFBS. Notably, differential expression
of NTM between two major brain regions linked to aggression
subtypes—prefrontal cortex and amygdala—was observed in
early prenatal stage of human brain development (P¼ 0.015,
http://www.brainspan.org).
Gene expression regulationduringneuronal development as one of
thepossiblemechanismsbehindaggressiveness in aADHDwas further
affirmed by our top associated lncRNA gene—ENST00000427806
(P¼ 3.04E-05, Supplementary Table SIV). The target gene of
this lncRNA has been predicted to be the protein-coding ST6
742 AMERICAN JOURNAL OF MEDICAL GENETICS PART B(alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalac-
tosaminide alpha-2,6-sialyltransferase 5 (ST6GALNAC5) gene
[Vucicevic et al., 2015]. The protein encoded by ST6GALNAC5 is a
member of sialyltransferases, with reported function in cell adhesion
through cell–cell and cell–extracellular matrix interactions [Tsuchida
et al., 2003]. Intriguingly, ST6GALNAC5, similarly to NTM, also
revealed differential expression in the aggression-related structures
of prefrontal cortex and amygdala in early prenatal stages of human
brain development (P¼ 0.013; http://www.brainspan.org).
As the adult measure of aggressiveness was derived from self-
reported experiences in childhood, we examined the possibility of
overlap of its GWA signals with those from GWA analyses of two
oppositional dimensions in a cADHD sample.We observed a slight
enrichment of association signals between the nominally associated
loci in aADHD and those observed in the GWA of both the defiant/
vindictive and the irritable ODD dimensions examined in cADHD
(Fig. 3). However, it is noteworthy that the aADHD and cADHD
samples were imputed using different reference panels with dispa-
rate genomic coverage.
Surprisingly, the correlationbetween thedirectionof effectsof the
aforementioned SNPs was negative (Fig. 3B and C). Such an inverse
relationship in effect directionality between parent-reported ODD
dimensions and adult retrospective report of childhood aggres-
siveness is most likely a chance finding due to our study being
under-powered. It might also be related to phenotypic and genetic
heterogeneity of the examined samples. There were considerable
differences in thepercentage of females between the aADHDand the
cADHD samples (Table I), which could indicate such mechanisms.
It has been shown that both age and sex are important factors in
genetic influences inADHDandaggression [Lyons et al., 1995;Miles
and Carey, 1997; Tuvblad and Baker, 2011; Faraone et al., 2015]. In
addition, the aggressiveness in the cADHD sample was determined
by parent-report, whereas in the aADHD sample, it was based on
retrospective self-report. The correlationbetweenparent-report and
self-report has been shown to be generally poor [Achenbach et al.,
1987], as also discussed in a recent study that found little overlap
between samples of cADHD and aADHD [Moffitt et al., 2015].
Hence, the measures of aggressiveness in the cADHD and the
aADHD samples are different. Furthermore, the youth and adult
ADHD samples may also be heterogeneous because childhood
ADHD does not always persist into adulthood [Faraone et al.,
2006; Moffitt et al., 2015]. Thus, to gain better understanding of
the genetic overlap between childhood aggression in aADHD and
oppositional dimensions in cADHD, this relationship should be
examined in larger sample using more rigorous statistical methods,
such as those developed to test specifically for genetic correlation
among various traits [Yang et al., 2011; Bulik-Sullivan et al.,
2015a,b]. This was not possible to implement in the current study
due to our modest sample size.
Examination of previously reported aggressiveness-related GWA
loci revealedmodest commonality in genetic architecture between the
childhood measures of aggressiveness in both cADHD and aADHD,
as well as in CD and anti-social personality disorder (Supplementary
Table SVIII). This observation may be in line with formerly reported
phenotypic overlap between these conditions, although to which
extent this overlap can be transmitted to various subtypes of aggres-
siveness remains to be determined [Storebo and Simonsen, 2013].This study should be viewed in light of its limitations. One
explanation for not observing any genome-wide significant loci
(P< 5.00E-08) could be our relatively modest sample size and
examination of common variants only (MAF> 1%). This study
had 63% power to detect common variants with small effect size of
explaining 0.5% of variability under an additive model and
an alpha level of 0.05 (http://genome.sph.umich.edu/wiki/
Power_Calculations: Quantitative_Traits). This may also be
observed in the distribution of the QQ plots (Supplementary
Fig. S3).
Another explanation for the lack of significant findings may lay
in phenotypic variability. Clinical heterogeneity may weaken true
association signals due to the use of different assessment protocols
or real genetic heterogeneity among subtypes of ADHD[McClellan
and King, 2010]. There are several methodological caveats to
assessing aggressiveness [Moffitt et al., 2015]. As our samples
consist of outpatients, we investigate a broader and perhaps
“softer” aspect of aggressiveness than say, for example, if we
were to study prison inmates and/or juvenile offenders. However,
this approach provides us with access to the vast majority of
aggressive behaviors, which may not come to be written in official
records [Moffitt, 2005]. Furthermore, we lack assessment of dif-
ferent subtypes of aggressive behavior that may be related to
different genotypes.
Considering the different direction of effects and different
measures of aggression in the cADHD and the aADHD samples,
analyzing the adult samples and the youth sample together could
potentially have obscured the genetic association signal. This is why
we refrained from performing meta-analysis across all samples.
Nonetheless, the WURS includes a host of symptoms related to
various elements of aggressiveness, which, based on our factor
analysis as well as previous research [Ward et al., 1993] seem to be
of key importance to the phenotype of aADHD, and the ODD
measures have also been validated in previous studies of cADHD
[Stringaris et al., 2012; Aebi et al., 2013]. Our approach may add to
the discussion of the Negative Valence System in the Research
Domain Criteria (RDoC) of the National Institute of Mental
Health (NIMH) of how to conceptualize and operationalize
aggressiveness as a dimension across different samples and dis-
orders [Verona and Bresin, 2015; Veroude et al., 2015].
We lacked information on current substance abuse in our
aADHD sample. Substance abuse is known to be frequently
comorbidwithADHDandmay confound the relationship between
ADHD and current aggressiveness. However, we utilized a retro-
spective measure of childhood aggressiveness that is likely to reflect
behavior over a longer period of time and should, thus, be less
affected by volatile environmental influences [Gulberg-Kj€ar and
Johansson, 2009].
Finally, since the genome-wide genotyping arrays consist of
SNPs only, wewere not able to assess the contribution of previously
reported variable tandem repeats (e.g., those in MAOA) that were
noted to be associated with aggressive behaviors and/or ADHD.
Taken together with evidence from previous studies, our results
implicate mechanisms of cell adhesion as well as regulation of gene
expression in the etiology of childhood aggressiveness in ADHD.
As there is a substantial degree of overlap in aggressiveness among
neuropsychiatric disorders, it could be beneficial to analyze
BREVIK ET AL. 743conditions where aggression is present together in order to pin-
point biological processes in dysfunctional forms of aggressiveness.
Further studies including samples of both children, adolescents and
adults, adopting multimodal measures and longitudinal designs
are warranted. Such studies may help our understanding as to
which extent various subtypes of aggression are mediated by
different mechanisms.ACKNOWLEDGMENTS
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